J Infect Dis:血浆病毒miRNA或可作为慢性活动型EB病毒感染分子标志

2013-07-04 潘风雨无阻 dxy

慢性活动型EB病毒感染(CAEBV)的临床特点类似于慢性或重复的感染性单核细胞增多症,如发热、淋巴结肿大等。CAEBV具有很高的发病率和死亡率,并伴随多种危及生命的并发症。造血干细胞移植已成为有效的治疗方法。血样本中的EB病毒DNA含量已被用于诊断疾病和评估疗效,但是,还没有发现能反映疾病严重程度、病程以及预后的其他生物标志物。miRNA属于小分子非编码RNA,与信使RNA的序列互补。已有研究表明

慢性活动型EB病毒感染(CAEBV)的临床特点类似于慢性或重复的感染性单核细胞增多症,如发热、淋巴结肿大等。CAEBV具有很高的发病率和死亡率,并伴随多种危及生命的并发症。造血干细胞移植已成为有效的治疗方法。血样本中的EB病毒DNA含量已被用于诊断疾病和评估疗效,但是,还没有发现能反映疾病严重程度、病程以及预后的其他生物标志物。

miRNA属于小分子非编码RNA,与信使RNA的序列互补。已有研究表明,EBV转染的细胞能够表达靶向于细胞和病毒DNA的miRNA。 由于miRNA易定量且稳定性高,所以这些分子或许可以作为EBV相关疾病的分子标志物。为了证实这一猜想,来自于日本名古屋研究生医学院的Yoshihiko Kawano和同事进行了一项研究,该研究结果在线发表于2013年5月17日的Journal of Infectious Diseases上。研究发现,血浆病毒miRNA或许可以作为慢性活动型EB病毒感染的分子标志。

该研究采用TaqMan 探针定量分析检测了2个EBV开放阅读框(BART 和BHRF)内编码的12种miRNA在血浆中的表达水平,研究共涉及了19例AEBV患者,14例传染性单细胞增多症患者以及11位健康对照者。
结果显示,CAEBV病人的血浆miR-BART-5p、2-5p、5和22均明显高于感染性单细胞增多症患者和健康对照组。并且,与无全身症状的CAEBV患者相比,伴随全身症状的CAEBV患者的血浆miR-BART2-5p、4、7、13、15与22水平明显上升。与血浆EB病毒负荷相反的是,miR-BART2-5p、13和15有与特殊临床情况相关的临床截止值。

研究发现,在CAEBV患者中,特异性血浆EBV miRNA 水平上升。因此,一些EBV miRNAs,尤其是miR-BART2-5p、13与15,可能成为反映疾病严重程度或预后的分子标志。


版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2037028, encodeId=5221203e028a8, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Fri Dec 27 19:02:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011832, encodeId=d64a2011832ac, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 21 16:02:00 CST 2013, time=2013-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930373, encodeId=dfb419303e3bb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Dec 22 08:02:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312250, encodeId=638f13122505a, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533788, encodeId=59f01533e88b2, content=<a href='/topic/show?id=47be64e04a' target=_blank style='color:#2F92EE;'>#EB病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6470, encryptionId=47be64e04a, topicName=EB病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ea12488352, createdName=zchen, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=)]
    2013-12-27 fyxzlh
  2. [GetPortalCommentsPageByObjectIdResponse(id=2037028, encodeId=5221203e028a8, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Fri Dec 27 19:02:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011832, encodeId=d64a2011832ac, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 21 16:02:00 CST 2013, time=2013-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930373, encodeId=dfb419303e3bb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Dec 22 08:02:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312250, encodeId=638f13122505a, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533788, encodeId=59f01533e88b2, content=<a href='/topic/show?id=47be64e04a' target=_blank style='color:#2F92EE;'>#EB病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6470, encryptionId=47be64e04a, topicName=EB病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ea12488352, createdName=zchen, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2037028, encodeId=5221203e028a8, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Fri Dec 27 19:02:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011832, encodeId=d64a2011832ac, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 21 16:02:00 CST 2013, time=2013-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930373, encodeId=dfb419303e3bb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Dec 22 08:02:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312250, encodeId=638f13122505a, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533788, encodeId=59f01533e88b2, content=<a href='/topic/show?id=47be64e04a' target=_blank style='color:#2F92EE;'>#EB病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6470, encryptionId=47be64e04a, topicName=EB病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ea12488352, createdName=zchen, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=)]
    2013-12-22 smallant2002
  4. [GetPortalCommentsPageByObjectIdResponse(id=2037028, encodeId=5221203e028a8, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Fri Dec 27 19:02:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011832, encodeId=d64a2011832ac, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 21 16:02:00 CST 2013, time=2013-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930373, encodeId=dfb419303e3bb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Dec 22 08:02:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312250, encodeId=638f13122505a, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533788, encodeId=59f01533e88b2, content=<a href='/topic/show?id=47be64e04a' target=_blank style='color:#2F92EE;'>#EB病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6470, encryptionId=47be64e04a, topicName=EB病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ea12488352, createdName=zchen, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=)]
    2013-07-06 Homburg
  5. [GetPortalCommentsPageByObjectIdResponse(id=2037028, encodeId=5221203e028a8, content=<a href='/topic/show?id=7c9f52681ca' target=_blank style='color:#2F92EE;'>#性活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52681, encryptionId=7c9f52681ca, topicName=性活动)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Fri Dec 27 19:02:00 CST 2013, time=2013-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011832, encodeId=d64a2011832ac, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 21 16:02:00 CST 2013, time=2013-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930373, encodeId=dfb419303e3bb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Dec 22 08:02:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312250, encodeId=638f13122505a, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533788, encodeId=59f01533e88b2, content=<a href='/topic/show?id=47be64e04a' target=_blank style='color:#2F92EE;'>#EB病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6470, encryptionId=47be64e04a, topicName=EB病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ea12488352, createdName=zchen, createdTime=Sat Jul 06 09:02:00 CST 2013, time=2013-07-06, status=1, ipAttribution=)]